A single-arm confirmatory study of definitive chemoradiation therapy including salvage treatment for clinical stage II/III esophageal squamous cell carcinoma …
H Takeuchi, Y Ito, R Machida, K Kato… - International Journal of …, 2022 - Elsevier
Purpose Definitive chemoradiotherapy (CRT) is the standard treatment for patients with
locally advanced esophageal cancer (EC) who refuse surgery as the initial therapy …
locally advanced esophageal cancer (EC) who refuse surgery as the initial therapy …
Incidental nodal irradiation in patients with esophageal cancer undergoing (chemo) radiation with 3D-CRT or VMAT
The extent of elective nodal irradiation (ENI) in patients undergoing definitive
chemoradiotherapy (dCRT) for esophageal squamous cell carcinoma (ESCC) remains …
chemoradiotherapy (dCRT) for esophageal squamous cell carcinoma (ESCC) remains …
Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II–III Esophageal Squamous Cell Carcinoma
H Zhu, X Lu, J Jiang, J Lu, X Sun, Y Zuo - Dose-Response, 2022 - journals.sagepub.com
Objective This study was conducted to explore the appropriate radical radiation dose in
concurrent chemoradiotherapy (CCRT) for patients with inoperable stage II–III esophageal …
concurrent chemoradiotherapy (CCRT) for patients with inoperable stage II–III esophageal …
[PDF][PDF] Co přináší protonová radioterapie nádorů jícnu?
P Vítek, J Kubeš - Onkologie, 2022 - solen.cz
The treatment strategy for esophageal cancer evolves continuously, with radiotherapy
having an irreplaceable position. The growing availability of proton beam therapy raises the …
having an irreplaceable position. The growing availability of proton beam therapy raises the …